Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47001-47050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05547698
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
NARecruiting
228 participants
Started: Sep 17, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor5 locations
NCT05509257
Naltrexone Neuroimaging in Teens with Eating Disorders
EARLY_PHASE1Recruiting
60 participants
Started: Sep 17, 2022 · Completed: Jun 30, 2027
5 conditions3 sponsors1 location
NCT05766046
Lung Cancer Prevention Screening Programme in Italy
NARecruiting
7,324 participants
Started: Sep 17, 2022 · Completed: Sep 30, 2026
3 conditions18 sponsors1 location
NCT05455515
The GISE (Società Italiana di Cardiologia Interventistica) - ShockCalcium Registry
N/ARecruiting
2,000 participants
Started: Sep 17, 2022 · Completed: Aug 1, 2026
1 condition4 sponsors1 location
NCT05607199
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
PHASE1Recruiting
80 participants
Started: Sep 16, 2022 · Completed: Oct 16, 2026
4 conditions1 sponsor5 locations
NCT05878028
L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC
PHASE2Recruiting
33 participants
Started: Sep 16, 2022 · Completed: Sep 15, 2025
1 condition1 sponsor1 location
NCT05447377
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants
PHASE3Recruiting
2,216 participants
Started: Sep 16, 2022 · Completed: Jan 30, 2024
1 condition1 sponsor2 locations
NCT06545877
REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)
N/ARecruiting
500 participants
Started: Sep 16, 2022 · Completed: Jun 22, 2029
1 condition1 sponsor1 location
NCT05442125
First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization
NARecruiting
1,146 participants
Started: Sep 16, 2022 · Completed: May 31, 2025
2 conditions27 sponsors28 locations
NCT05206955
Study of Tadalafil Vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
PHASE3Recruiting
80 participants
Started: Sep 16, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT04681339
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
N/ARecruiting
200 participants
Started: Sep 16, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05298748
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
NARecruiting
34 participants
Started: Sep 16, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT05766410
A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC
PHASE2Recruiting
60 participants
Started: Sep 16, 2022 · Completed: Sep 30, 2026
3 conditions1 sponsor2 locations
NCT05345587
Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy
NARecruiting
196 participants
Started: Sep 16, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor6 locations
NCT05219331
Hydrocephalus Treatment on Persistent Disorder of Consciousness
NARecruiting
20 participants
Started: Sep 16, 2022 · Completed: Apr 1, 2025
1 condition1 sponsor2 locations
NCT05550090
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
N/ARecruiting
40 participants
Started: Sep 16, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06078605
Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients
NARecruiting
80 participants
Started: Sep 16, 2022 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT05867173
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
NARecruiting
200 participants
Started: Sep 16, 2022 · Completed: Mar 31, 2027
1 condition3 sponsors2 locations
NCT04264065
Albumin and Prognosis of Severely Patients Burns
N/ARecruiting
200 participants
Started: Sep 16, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05534607
Natives Engaged in Alzheimers Research - 'Ike Kupuna
NARecruiting
192 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2027
2 conditions1 sponsor3 locations
NCT05879783
Optical Biopsy for Peritoneal Nodules in Colorectal Patients
NARecruiting
278 participants
Started: Sep 15, 2022 · Completed: Dec 15, 2027
1 condition1 sponsor1 location
NCT05763602
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
PHASE4Recruiting
2,000 participants
Started: Sep 15, 2022 · Completed: Feb 15, 2026
1 condition8 sponsors6 locations
NCT06617650
GenerationGemelli: Longitudinal Study for the Evaluation of the Maternal Exposome on the Health of the Newborn and Child
N/ARecruiting
140 participants
Started: Sep 15, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05546307
Interest of Prior Relaxation on the Recordings of the SomatoSensory Evoked Potentials
NARecruiting
242 participants
Started: Sep 15, 2022 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT05501925
GlideSheath Slender® Versus Conventional 6 French Arterial Sheath: Impact on the Distal Radial Artery Occlusion (SMART)
NARecruiting
600 participants
Started: Sep 15, 2022 · Completed: Feb 28, 2024
2 conditions1 sponsor1 location
NCT05652192
SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
PHASE2Recruiting
37 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05539794
Exercise and Lifestyle in Adolescent Cancer (HEALTHYADOL)
NARecruiting
136 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05336968
Triamcinolone Ketorolac (TriKe) Knee Trial
PHASE4Recruiting
150 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03886025
Combined Anodal Transcranial Direct Current Stimulation (tDCS) and Cognitive Training and Decision-making
NARecruiting
60 participants
Started: Sep 15, 2022 · Completed: Dec 30, 2026
2 conditions2 sponsors1 location
NCT04428658
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
NARecruiting
82 participants
Started: Sep 15, 2022 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05304442
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
PHASE3Recruiting
40 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT05737381
Quality of Human Embryos in IVF, Culturing in Differentiated Oxygen
NARecruiting
350 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT04166656
Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.
PHASE3Recruiting
84 participants
Started: Sep 15, 2022 · Completed: Oct 31, 2028
1 condition6 sponsors1 location
NCT05758961
Le French Gut: Characterization of Gut Microbiota Profiles in France
N/ARecruiting
100,000 participants
Started: Sep 15, 2022 · Completed: Sep 15, 2042
1 condition2 sponsors1 location
NCT05201144
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
PHASE2Recruiting
40 participants
Started: Sep 15, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT05409872
Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids
NARecruiting
108 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05278494
Dextromethorphan for Treatment of Postoperative Pain
NARecruiting
160 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05576961
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody
PHASE1/PHASE2Recruiting
60 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT06954961
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
PHASE3Recruiting
640 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05519449
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
PHASE1Recruiting
272 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor26 locations
NCT05325034
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NARecruiting
2,000 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
4 conditions2 sponsors22 locations
NCT04862637
Detecting the Changes of Swallowing Function in Oral Cancer Patients
N/ARecruiting
40 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05272254
Povidone Iodine Efficacy Study
PHASE2Recruiting
246 participants
Started: Sep 15, 2022 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT04789616
The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke
PHASE2Recruiting
120 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
1 condition10 sponsors6 locations
NCT05307263
Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease
NARecruiting
300 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06378216
Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]
N/ARecruiting
30 participants
Started: Sep 15, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05620121
ACute Treatment of Incisional Ventral Hernia
N/ARecruiting
500 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT06426420
Endometriosis and ATR-FTIR Spectroscopy
NARecruiting
600 participants
Started: Sep 15, 2022 · Completed: Apr 29, 2026
2 conditions2 sponsors1 location
NCT05482568
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer
PHASE1/PHASE2Recruiting
324 participants
Started: Sep 15, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor2 locations
NCT05502380
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
PHASE3Recruiting
1,100 participants
Started: Sep 15, 2022 · Completed: Dec 12, 2025
3 conditions1 sponsor1 location